QHSLab, Inc. Files 8-K for Disclosure and Exhibits
Ticker: USAQ · Form: 8-K · Filed: Sep 25, 2024 · CIK: 856984
Sentiment: neutral
Topics: disclosure, filing, exhibits
TL;DR
QHSLab filed an 8-K on 9/25/24 for disclosures and exhibits.
AI Summary
On September 25, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statements and Exhibits. The company, formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, is incorporated in Nevada and operates in the Surgical & Medical Instruments & Apparatus industry.
Why It Matters
This 8-K filing provides important updates and disclosures for QHSLab, Inc., which could impact investor understanding of the company's current status and financial reporting.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain significant negative news or events.
Key Players & Entities
- QHSLab, Inc. (company) — Registrant
- September 25, 2024 (date) — Date of earliest event reported
- USA EQUITIES CORP. (company) — Former company name
- AMERICAN BIOGENETIC SCIENCES INC (company) — Former company name
- Nevada (jurisdiction) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing for QHSLab, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 25, 2024.
What industry does QHSLab, Inc. operate in?
QHSLab, Inc. operates in the Surgical & Medical Instruments & Apparatus industry, with SIC code 3841.
What were some of QHSLab, Inc.'s former company names?
QHSLab, Inc. was formerly known as USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC.
In which state is QHSLab, Inc. incorporated?
QHSLab, Inc. is incorporated in Nevada.
Filing Stats: 683 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2024-09-25 09:00:40
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value USAQ N/A Item 7.01 Regu
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 87KB
- 0001493152-24-038060.txt ( ) — 345KB
- usaq-20240925.xsd (EX-101.SCH) — 3KB
- usaq-20240925_lab.xml (EX-101.LAB) — 33KB
- usaq-20240925_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 25, 2024 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman